NVNO
NVNO
NASDAQ · Health Care

Envveno Medical Corp

$10.50
+0.37 (+3.65%)
Financial Highlights (FY 2025)
Revenue
4.05M
Net Income
325.5K
Gross Margin
45.1%
Profit Margin
8.0%
Rev Growth
+1.6%
D/E Ratio
0.35
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 45.1% 45.1% 45.1%
Operating Margin 8.3% 8.6% 9.4%
Profit Margin 8.0% 6.8% 7.9%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 4.05M 4.29M 3.77M
Gross Profit 1.83M 1.93M 1.70M
Operating Income 337.2K 367.9K 355.8K
Net Income 325.5K 290.5K 296.6K
Gross Margin 45.1% 45.1% 45.1%
Operating Margin 8.3% 8.6% 9.4%
Profit Margin 8.0% 6.8% 7.9%
Rev Growth +1.6% +1.7% -4.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 1.56M 1.94M 1.63M
Total Equity 4.50M 4.44M 4.62M
D/E Ratio 0.35 0.44 0.35
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 536.9K 620.7K 487.7K
Free Cash Flow 213.8K 290.5K 219.2K